Pier Capital’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-83,100
Closed -$11.4M 136
2018
Q2
$11.4M Buy
83,100
+43,553
+110% +$3.96M 1.56% 1
2018
Q1
$3.11M Sell
39,547
-32,405
-45% -$2.39M 0.53% 94
2017
Q4
$4.91M Sell
71,952
-68,610
-49% -$3.56M 0.84% 83
2017
Q3
$5.65M Sell
140,562
-13,539
-9% -$522K 0.98% 63
2017
Q2
$6.13M Buy
+154,101
New +$5.64M 1.06% 25
2013
Q4
Sell
-160,149
Closed -$6.35M 161
2013
Q3
$6.35M Buy
+160,149
New +$5.9M 0.9% 77

Pier Capital's FMI Position: Q3 2018 in Review

Pier Capital sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 83,100 shares — an estimated $11.4M sold.

Pier Capital first reported a position in FMI in Q3 2013 and held it in 6 quarters. The position peaked at $11.4M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • Pier Capital reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • Pier Capital sold 83,100 Foundation Medicine, Inc. shares in Q3 2018, an estimated $11.4M.
  • Pier Capital first reported a position in Foundation Medicine, Inc. in Q3 2013 and held it in 6 quarters.
  • Pier Capital's Foundation Medicine, Inc. position peaked at $11.4M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Pier Capital's 13F filing for Q3 2018, filed 14 Nov 2018.